Compare DMRC & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DMRC | KRMD |
|---|---|---|
| Founded | 2008 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.6M | 177.8M |
| IPO Year | 2008 | 2019 |
| Metric | DMRC | KRMD |
|---|---|---|
| Price | $9.48 | $3.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $10.00 | $6.50 |
| AVG Volume (30 Days) | ★ 276.6K | 100.1K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.58 | ★ 53.85 |
| EPS | N/A | ★ N/A |
| Revenue | $25,213,000.00 | ★ $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 15.69 | ★ 22.23 |
| 52 Week Low | $4.07 | $2.91 |
| 52 Week High | $17.47 | $6.61 |
| Indicator | DMRC | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 38.41 | 44.43 |
| Support Level | $9.52 | $3.82 |
| Resistance Level | $10.31 | $4.28 |
| Average True Range (ATR) | 1.26 | 0.15 |
| MACD | -0.68 | -0.01 |
| Stochastic Oscillator | 3.78 | 18.53 |
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.